Stemline Therapeutics Inc (NASDAQ:STML)

15.19
Delayed Data
As of Feb 27
 -1.01 / -6.23%
Today’s Change
10.50
Today|||52-Week Range
29.50
-10.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
AssetsCash----2.0M2.8M
 
 
 
Short Term Investment Cash-2.0M-1.4M-3.8M42.2M
 
 
 
 
 
Cash & Short Term Investments7.2M28.4M2.0M44.2M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.00199.6K
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets276.5K223.2K299.1K292.9K
 
 
 
 
 
Current Assets7.5M28.6M2.3M44.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross0.000.00--460.0K
 
 
Depreciation0.000.00---76.7K
 
 
Other Assets0.00400.0K2.7M0.00
 
 
 
Total Assets7.5M29.0M5.0M85.3M
 
 
 
 
 
 
LiabilitiesAccrued Expenses583.6K1.5M5.4M2.7M
 
 
 
 
 
Other Current Liabilities583.6K1.5M5.4M3.0M
 
 
 
 
 
Other Liabilities634.3K1.6M5.5M5.0M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt927.5K--2.0M0.00
 
 
 
Other Liabilities89.6K1.2M30.4K0.00
 
 
 
 
Total Liabilities1.7M2.8M7.5M5.7M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity5.9M26.2M-2.5M79.6M
 
 
 
 
 
Total Shareholder Equity5.9M26.2M-2.5M79.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding--7.0M7.5M13.1M
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account